Abstract/References

H3K4 methylation, primarily mediated by MLL family proteins, plays a pivotal role in the epigenetic regulation of gene transcription. Among the MLL family, KMT2A is known for its critical role in hematopoiesis. MLL family proteins feature C-terminal SET catalytic domains, requiring the formation of MLL complexes with proteins like DPY30 to maximize their enzymatic activity. Deletion of DPY30 results in a significant reduction in H3K4me1, H3K4me2, and H3K4me3 levels in bone marrow (BM) cells, underscoring the essential role of DPY30 in facilitating optimal catalytic activity within MLL family complexes. Here, we present a unique case of myelodysplastic neoplasms (MDS) associated with a novel t(2;19)(p23;q13.3) translocation. A 22-year-old pregnant woman initially sought consultation due to thrombocytopenia, which temporarily improved following a miscarriage. However, she later presented with progressive pancytopenia. RNA sequencing analysis of BM mononuclear cells using STAR-Fusion revealed the translocation breakpoint on chromosomes, resulting in the disruption of the DPY30 and CEACAM6 genes. BM failure showed marked improvement following cord blood transplantation. This case represents a novel form of MDS associated with the disruption of the DPY30 gene. Our findings underscore the importance of considering early hematopoietic stem cell transplantation for MDS cases attributed to DPY30 dysfunction.

1. Yang Z, Augustin J, Chang C, Hu J, Shah K, Chang CW, et al.　The DPY30 subunit in SET1/MLL complexes regulates the proliferation and differentiation of hematopoietic progenitor cells.　Blood, 124:2025-2033, 2014.

2. Zhao A, Zhou H, Yang J, Li M, Niu T.　Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies.　Signal Transduct Target Ther, 8:71, 2023.

3. Khan I, Amin MA, Eklund EA, Gartel AL.　Regulation of HOX gene expression in AML.　Blood Cancer J, 14:42, 2024.

4. Zhao L, Huang N, Mencius J, Li Y, Xu Y, Zheng Y, et al.　DPY30 acts as an ASH2L-specific stabilizer to stimulate the enzyme activity of MLL family methyltransferases on different substrates.　iScience, 25:104948, 2022.

5. Haddad JF, Yang Y, Takahashi YH, Joshi M, Chaudhary N, Woodfin AR, et al.　Structural Analysis of the Ash2L/Dpy-30 Complex Reveals a Heterogeneity in H3K4 Methylation.　Structure, 26:1594-603 e4, 2018.

6. Yang Z, Shah K, Khodadadi-Jamayran A, Jiang H.　Dpy30 is critical for maintaining the identity and function of adult hematopoietic stem cells.　J Exp Med, 213:2349-2364, 2016.

7. Rose R, Golosova O, Sukhomlinov D, Tiunov A, Prosperi M.　Flexible design of multiple metagenomics classification pipelines with UGENE.　Bioinformatics, 35:1963-1965, 2019.

8. Lavallee VP, Baccelli I, Krosl J, Wilhelm B, Barabe F, Gendron P, et al.　The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias.　Nat Genet, 47:1030-1037, 2015.

9. Andersson AK, Ma J, Wang J, Chen X, Gedman AL, Dang J, et al.　The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias.　Nat Genet, 47:330-337, 2015.

10. Kouzarides T.　Chromatin modifications and their function.　Cell, 128:693-705, 2007.

11. Jiang H, Shukla A, Wang X, Chen WY, Bernstein BE, Roeder RG.　Role for Dpy-30 in ES cell-fate specification by regulation of H3K4 methylation within bivalent domains.　Cell, 144:513-525, 2011.